联合放疗在头颈部鳞状细胞癌患者的治疗中具有重要意义。
Adjuvant radiotherapy plays an important role in the treatment of patients with head and neck SCC.
后续，尤其是在术后第一年，在头颈部鳞状细胞癌管理是必不可少的。
Follow-up, especially within the first postoperative year, is essential in managing head and neck SCC.
目的观察32P胶体组织间注射治疗晚期头颈部鳞状细胞癌（简称鳞癌）的临床疗效。
OBJECTIVE To observe the effect of 32P intertissue injection on advanced head and neck cancer.
结论：食道癌患者中头颈部鳞状细胞癌的发病率为11.4%。定期对原发性食道癌患者进行耳鼻喉科检查和咽镜检查可以检出早期头颈部鳞状细胞癌。
Conclusion: The incidence of SCCHN in our EC patients was 11.4%. Periodic otolaryngological examination and pharyngoscopy screening can detect SCCHNs early in patients with primary EC.
结论：食道癌患者中头颈部鳞状细胞癌的发病率为11.4%。定期对原发性食道癌患者进行耳鼻喉科检查和咽镜检查可以检出早期头颈部鳞状细胞癌。
Conclusion: The incidence of SCCHN in our EC patients was 11.4%. Periodic otolaryngological examination and pharyngoscopy screening can detect SCCHNs early in patients with primary EC.
应用推荐